Over the past funding period Development Funds were allocated primarily in support of new faculty recruitment, pilot projects, and to a lesser extent development of new shared resources. Funds in this category in the CCSG were limited to approximately $200K per year due to budgetary constraints following the last re-competition. Developmental funds and AECC resources, in general, were targeted to address areas of concern identified at the last CCSG review and areas assigned high priority by the senior leadership based upon the outcome of the Center's internal and external review processes. Over the past funding period a total of $1.21M was allocated to Developmental Funds from the CCSG. Of this, 38% was allocated to New Investigator Support, 37% for Pilot Projects, and 25% for New Shared Resources. There will be considerable opportunities for AECC faculty recruitment and pilot project funding that will accompany the opening of the new Michael F. Price Center for Genetic and Translational Medicine over the next funding period. There are developing shared resources that will be targeted for Developmental funds. It is anticipated that 40% of Developmental Funds will be utilized for faculty recruitment, 40% for pilot projects, and 20% for new shared resources. In this application $250,000 is requested in year one for Developmental Funds.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA013330-38
Application #
8113373
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2010-07-01
Budget End
2011-06-30
Support Year
38
Fiscal Year
2010
Total Cost
$365,464
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
DUNS #
110521739
City
Bronx
State
NY
Country
United States
Zip Code
10461
Racine, Jeremy J; Stewart, Isabel; Ratiu, Jeremy et al. (2018) Improved Murine MHC-Deficient HLA Transgenic NOD Mouse Models for Type 1 Diabetes Therapy Development. Diabetes 67:923-935
Frimer, Marina; Miller, Eirwen M; Shankar, Viswanathan et al. (2018) Adjuvant Pelvic Radiation ""Sandwiched"" Between Paclitaxel/Carboplatin Chemotherapy in Women With Completely Resected Uterine Serous Carcinoma: Long-term Follow-up of a Prospective Phase 2 Trial. Int J Gynecol Cancer 28:1781-1788
Kale, Abhijit; Ji, Zhejun; Kiparaki, Marianthi et al. (2018) Ribosomal Protein S12e Has a Distinct Function in Cell Competition. Dev Cell 44:42-55.e4
Lee, Chang-Hyun; Kiparaki, Marianthi; Blanco, Jorge et al. (2018) A Regulatory Response to Ribosomal Protein Mutations Controls Translation, Growth, and Cell Competition. Dev Cell 46:456-469.e4
Mao, Serena P H; Park, Minji; Cabrera, Ramon M et al. (2018) Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth. Breast Cancer Res 20:131
Mocholi, Enric; Dowling, Samuel D; Botbol, Yair et al. (2018) Autophagy Is a Tolerance-Avoidance Mechanism that Modulates TCR-Mediated Signaling and Cell Metabolism to Prevent Induction of T Cell Anergy. Cell Rep 24:1136-1150
Yang, Chia-Ping Huang; Wang, Changwei; Ojima, Iwao et al. (2018) Taxol Analogues Exhibit Differential Effects on Photoaffinity Labeling of ?-Tubulin and the Multidrug Resistance Associated P-Glycoprotein. J Nat Prod 81:600-606
Guan, Fangxia; Tabrizian, Tahmineh; Novaj, Ardijana et al. (2018) Dietary Walnuts Protect Against Obesity-Driven Intestinal Stem Cell Decline and Tumorigenesis. Front Nutr 5:37
Wang, Tao; Hosgood, H Dean; Lan, Qing et al. (2018) The Relationship Between Population Attributable Fraction and Heritability in Genetic Studies. Front Genet 9:352
Chennamadhavuni, Divya; Saavedra-Avila, Noemi Alejandra; CarreƱo, Leandro J et al. (2018) Dual Modifications of ?-Galactosylceramide Synergize to Promote Activation of Human Invariant Natural Killer T Cells and Stimulate Anti-tumor Immunity. Cell Chem Biol 25:571-584.e8

Showing the most recent 10 out of 1508 publications